Interestingly, previous in vitro investigation reported a cell cycle arrest in the G1 phase in liver cancer cells treated with ponatinib, and identified that this cell cycle blockade was mediated by a reduction in the function of the CDK4/CDK6/Cyclin D1 complex (Liu et al., 2019). This evidence concerns the gene CCND1 and liver cancer.